DXCM
DexCom, Inc.
DexCom, Inc. (DXCM) manufactures continuous glucose monitoring systems for diabetes management, with its most significant political signal being $4.3M in annual payments to doctors and two active congressional traders.
Govt Dependence
65/100
Regulatory Density
85/100
Lobbying Intensity
0/100
Political Signal
NEUTRAL
BusinessWhat DXCM does
DexCom develops, manufactures, and distributes continuous glucose monitoring (CGM) systems for diabetes management. Its revenue is derived from the sale of CGM sensors, transmitters, and related software, primarily to patients, healthcare providers, and through pharmacy benefit channels. The company operates in the highly regulated medical device sector under FDA oversight and is subject to Medicare/Medicaid reimbursement policies.
12 months past · 3 months futureDXCM activity timeline
Congress
buy
sell
Insider · Form 4
open-market buy
Hedge fund · 13F
opened
+ added
− trimmed
closed
holds
Bills
past action (this ticker)
upcoming markup (sector)
★ carveout (this ticker)
240 trading days ·
27 congressional trades shown
·
0 insider buys
·
0 13F filings
·
1 past bill actions
·
16 upcoming markups
Lifetime Government AwardsDXCM federal contracts by year
$4K
total awarded · 2017–2017
1
contracts on file
2017
peak year ($4K)
Top contracts by award amount
$4K
Department of Health and Human Serv
2017-08-22
IGF::OT::IGF PLATINUM RECEIVER
1 years · 1 contracts
Politicians Trading DXCMMembers of Congress with recent DXCM positions
7 politicians traded DXCM across 59 disclosed transactions totaling $1.6M (last 730 days).
Greed score = composite of trade frequency, volume & recency across the politician's entire history (not just DXCM). 0-30 LOW · 30-60 MID · 60+ HIGH.
Michael T. McCaul
12 buys
8 sells
$624K
2025-10-27
LOW · 0
Tina Smith
2 sells
$350K
2026-05-07
LOW · 1
Jefferson Shreve
2 buys
4 sells
$195K
2025-05-12
LOW · 0
Ro Khanna
10 buys
12 sells
$176K
2026-04-13
LOW · 0
Kevin Hern
2 sells
$150K
2024-12-31
LOW · 1
Robert P. Bresnahan
4 buys
2 sells
$48K
2025-05-15
LOW · 0
John Boozman
1 buy
$8K
2026-01-26
MID · 47
Congressional TradesWho in Congress is trading DXCM
2026-04-13
Ro Khanna
Purchase
$1,001 - $15,000
2026-04-29
Tina Smith
Sale (Partial)
$100,001 - $250,000
2026-05-07
Tina Smith
Sale (Full)
$100,001 - $250,000
2026-01-26
John Boozman
Purchase
$1,001 - $15,000
2026-01-29
Ro Khanna
Purchase
$1,001 - $15,000
2025-10-27
Michael T. McCaul
Sale
$15,001 - $50,000
2025-10-27
Michael T. McCaul
sale
$15,001 - $50,000
2025-09-22
Michael T. McCaul
Purchase
$1,001 - $15,000
2025-09-22
Michael T. McCaul
purchase
$1,001 - $15,000
2025-09-29
Ro Khanna
Sale
$1,001 - $15,000
2025-09-29
Ro Khanna
sale
$1,001 - $15,000
2025-08-04
Michael T. McCaul
purchase
$15,001 - $50,000
30+ trades on file · most recent 2026-05-13
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
Stock awards & option exercises
7
stock awards · $11.0M market value
2026-03-08
Coleman Jon
EVP, Chief Commercial Officer
AWARD
43,897 sh
$3.0M
2026-02-26
Osterloh Albert Frederick IV
Director
AWARD
7,061 sh
$525K
2026-01-29
SAYER KEVIN R
Executive Chair
AWARD
71,218 sh
$5.3M
2026-01-29
Leach Jacob Steven
President, CEO, and Director
AWARD
8,310 sh
$615K
2026-01-29
Stern Sadie
EVP, Chief HR Officer
AWARD
7,123 sh
$527K
2026-01-29
Sylvain Jereme M
EVP, Chief Financal Officer
AWARD
7,123 sh
$527K
2026-01-29
Brown Michael Jon
EVP, Chief Legal Officer
AWARD
7,123 sh
$527K
For DXCM, executives receive stock primarily as compensation rather than via open-market purchases — typical for established large-cap firms.
Bills Affecting DXCMLive legislation impacting this stock
HR.1860 · 119th
Women Veterans Cancer Care Coordination Act
HRES.185 · 119th
Recognizing the need of Congress to prevent, address, and treat obesity as a disease in the United States on this World Obesity Da
HR.1784 · 119th
Medicare Fraud Detection and Deterrence Act of 2025
HRES.180 · 119th
Supporting the designation of March 2025 as National Colorectal Cancer Awareness Month.
HR.1806 · 119th
Triple-Negative Breast Cancer Research and Education Act of 2025
S.786 · 119th
Public Health Funding Restoration Act
S.574 · 118th
Increasing Prescription Drug Competition Act
S.669 · 118th
Increasing Mental Health Options Act of 2023
S.708 · 118th
A bill to improve outcomes for Medicaid beneficiaries with major depressive disorder or other mental health conditions.
SRES.90 · 118th
A resolution recognizing the significance of endometriosis as an unmet chronic disease for women and designating March 2023 as "En
Political ProfileWhere DXCM sits in Washington
[object Object]
STRUCTURAL: High regulatory exposure (85 score) and government dependence (65 score) with 8 identified healthcare bills. EVIDENTIARY: Significant doctor payment program ($4.3M in 2023, per `get_political_influence.doctor_payments`), active congressional trading (2 members, 9 trades), and a single corporate insider purchase cluster ($1.86M, per `get_corporate_insider_signal`). Net: Evidentiary signals of commercial and political engagement are offset by a lack of direct lobbying or donation infrastructure.
Regulatory ExposureThreats & opportunities
Regulatory threats
-
Medicare/Medicaid reimbursement rate changesCenters for Medicare & Medicaid Services (CMS)"High regulatory density score (85) and multiple healthcare sector bills with revenue impact, per `Recent bill_impacts`."
Regulatory opportunities
-
Expanded coverage for CGM systems under federal health programsCenters for Medicare & Medicaid Services (CMS)"High government dependence score (65) and healthcare sector bill impacts, per `Recent bill_impacts`."
Capitol Hill AlliesChampions & critics
Congressional champions
Congressional critics
- No specific congressional critics identified.
Member intelligence layer
Live signals + predictions for DXCM — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades DXCM
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord
Frequently AskedAbout DXCM & political exposure
Does DexCom, Inc. (DXCM) hold federal contracts?
Yes. DexCom, Inc. has 1 federal contract awards totaling $4,186, primarily from agencies including Department of Health and Human Services. See full contract list and amounts on this page.
Has Congress traded DXCM stock?
201 congressional trades by 14 unique members of Congress, most recently on 2026-05-07. See the Congressional Trading panel for politician-by-politician breakdown.
What is DXCM political risk profile?
Government dependence: 65/100. Lobbying intensity: 0/100. Political signal: neutral. Donor party split: R 0% / D 0%.
How does GovGreed track DXCM political activity?
GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. DXCM data is updated daily from these official federal sources.